BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9776835)

  • 1. Effect of Pichia anomala killer toxin on Candida albicans.
    Mathews HL; Conti S; Witek-Janusek L; Polonelli L
    Med Mycol; 1998 Aug; 36(4):199-204. PubMed ID: 9776835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Candida albicans activity of Pichia anomala as determined by a growth rate reduction assay.
    Sawant AD; Abdelal AT; Ahearn DG
    Appl Environ Microbiol; 1988 May; 54(5):1099-103. PubMed ID: 3291760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Killer factor interference in mixed opportunistic yeast cultures.
    Conti S; Cantelli C; Gerloni M; Fisicaro P; Magliani W; Bertolotti D; Mozzoni P; Sullivan D; Coleman D; Polonelli L
    Mycopathologia; 1996; 135(1):1-8. PubMed ID: 9008877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity.
    Magliani W; Conti S; de Bernardis F; Gerloni M; Bertolotti D; Mozzoni P; Cassone A; Polonelli L
    Nat Biotechnol; 1997 Feb; 15(2):155-8. PubMed ID: 9035141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of a cell wall receptor in the mode of action of an anti-Candida toxin of Pichia anomala.
    Sawant AD; Ahearn DG
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1331-5. PubMed ID: 2201251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ion channel activity by Pichia membranifaciens killer toxin.
    Santos A; Marquina D
    Yeast; 2004 Jan; 21(2):151-62. PubMed ID: 14755640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of the anti-Candida toxin of Pichia anomala WC 65.
    Sawant AD; Abdelal AT; Ahearn DG
    Antimicrob Agents Chemother; 1989 Jan; 33(1):48-52. PubMed ID: 2653213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between killer yeasts and pathogenic fungi.
    Walker GM; McLeod AH; Hodgson VJ
    FEMS Microbiol Lett; 1995 Apr; 127(3):213-22. PubMed ID: 7758935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-scale screening of selected Candida maltosa, Debaryomyces hansenii and Pichia anomala killer toxin activity against pathogenic yeasts.
    Buzzini P; Martini A
    Med Mycol; 2001 Dec; 39(6):479-82. PubMed ID: 11798052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human natural yeast killer toxin-like candidacidal antibodies.
    Polonelli L; De Bernadis F; Conti S; Boccanera M; Magliani W; Gerloni M; Cantelli C; Cassone A
    J Immunol; 1996 Mar; 156(5):1880-5. PubMed ID: 8596040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Killer system: a simple method for differentiating Candida albicans strains.
    Polonelli L; Archibusacci C; Sestito M; Morace G
    J Clin Microbiol; 1983 May; 17(5):774-80. PubMed ID: 6345575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaerobic yeast killer systems.
    Polonelli L; Menozzi MG; Campani L; Gerloni M; Conti S; Morace G; Chezzi C
    Eur J Epidemiol; 1992 May; 8(3):471-6. PubMed ID: 1397211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrimination between Candida albicans and other pathogenic species of the genus Candida by their differential sensitivities to toxins of a panel of killer yeasts.
    Buzzini P; Martini A
    J Clin Microbiol; 2001 Sep; 39(9):3362-4. PubMed ID: 11526179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of Pneumocystis carinii to a Pichia anomala killer toxin.
    Séguy N; Aliouat EM; Dei-Cas E; Polonelli L; Camus D; Cailliez JC
    J Eukaryot Microbiol; 1994; 41(5):109S. PubMed ID: 7804202
    [No Abstract]   [Full Text] [Related]  

  • 15. Yeast killer toxin-like anti-idiotypic antibodies.
    Polonelli L; Morace G
    J Clin Microbiol; 1988 Mar; 26(3):602-4. PubMed ID: 2451680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the killer toxin of several yeasts and the purification of a toxin of type K2.
    Pfeiffer P; Radler F
    Arch Microbiol; 1984 Apr; 137(4):357-61. PubMed ID: 6375620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immuno-crossreactivity of an anti-Pichia anomala killer toxin monoclonal antibody with a Williopsis saturnus var. mrakii killer toxin.
    Guyard C; Evrard P; Corbisier-Colson AM; Louvart H; Dei-Cas E; Menozzi FD; Polonelli L; Cailliez J
    Med Mycol; 2001 Oct; 39(5):395-400. PubMed ID: 12054049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a killer toxin of Pichia anomala to Pneumocystis. Perspectives in the control of pneumocystosis.
    Séguy N; Polonelli L; Dei-Cas E; Cailliez JC
    FEMS Immunol Med Microbiol; 1998 Sep; 22(1-2):145-9. PubMed ID: 9792073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of two different toxins of Wickerhamomyces anomalus (Pichia anomala) VKM Y-159.
    Farkas Z; Márki-Zay J; Kucsera J; Vágvölgyi C; Golubev WI; Pfeiffer I
    Acta Biol Hung; 2012 Jun; 63(2):277-87. PubMed ID: 22695525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rapid identification and susceptibility to killer toxins of yeasts isolated from non-systemic mycoses].
    Sangorrín MP; Lopes CA; Rivero A; Caballero AC
    Rev Argent Microbiol; 2007; 39(4):230-6. PubMed ID: 18390160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.